にゃんごう＆いがさんのEBMerな夜第51回放送　2021/3/26 【にゃんごう：COVID-19後遺症】 Writing Committee for the COMEBAC Study Group, Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, Gasnier M, Lecoq AL, Meyrignac O, Noel N, Baudry E, Bellin MF, Beurnier A, Choucha W, Corruble E, Dortet L, Hardy-Leger I, Radiguer F, Sportouch S, Verny C, Wyplosz B, Zaidan M, Becquemont L, Montani D, Monnet X. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA. 2021 Mar 17. doi: 10.1001/jama.2021.3331. PMID: 33729425. https://jamanetwork.com/journals/jama/fullarticle/2777787 【いがさん：NASHに対する皮下注GLP-1受容体作動薬】 Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal AJ, Sejling AS, Harrison SA; NN9931-4296 Investigators. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. N Engl J Med. 2021 Mar 25;384(12):1113-1124. doi: 10.1056/NEJMoa2028395. Epub 2020 Nov 13. PMID: 33185364. https://www.nejm.org/doi/full/10.1056/NEJMoa2028395 リスナーアンケートにご協力下さい！！ https://goo.gl/forms/5AsPilK7QnB9VrmX2

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related